Consumer advocates have criticised the federal government’s decision to approve a 4.41% average rise in private health insurance premiums – the steepest in nearly a decade – warning the hike will deepen financial strain for millions of Australians at a time when household budgets are already stretched.
The increase, announced by health minister Mark Butler on Tuesday, takes effect April 1, 2026, and affects around 15 million policyholders. It follows a recent interest rate hike and sustained cost-of-living pressure that has pushed many families to the financial edge.
Financial comparison website Canstar estimates an individual with an average-priced Gold hospital policy could see annual costs rise by $167, while families on an equivalent policy face an average increase of $330, based on a policyholder earning the average wage of $104,807 with the relevant private health insurance rebate applied.
Butler said the rise was driven by a 5% surge in medical and hospital costs over the last financial year and noted that insurers were required to resubmit their applications multiple times before the government settled on the industry average.
“This year’s decision reinforces that premium increases must be backed by clear evidence and contribute to system-wide improvements, not just insurer balance sheets,” Butler said.
Private Healthcare Australia chief executive Dr. Rachel David defended the rise, saying health funds were working to balance the affordability of insurance with the rising costs of providing care. “More people are using their health insurance for high-cost hospital care such as joint replacements and cancer treatment, and the cost of delivering care continues to rise,” David said. “If health funds could keep premiums the same without jeopardising their ability to pay claims, they would. The industry is acutely aware of how tough many Australians are doing it right now.”
Canstar data insights director Sally Tindall was among the first to respond. “The highest government-approved price hike since 2017 is not what the doctor ordered for households battling cost-of-living pressures,” Tindall said, adding that “this 4.41% price hike will go down like foul-tasting medicine for Australians already juggling higher mortgage repayments, electricity, and grocery bills.”
Elizabeth Deveny, chief executive of the Consumers Health Forum – the national peak body for healthcare consumers – questioned the value of the current system. “If premiums are rising faster than wages and inflation, people are asking: are we getting better protection, clearer coverage, and fewer surprise bills?” Deveny said. “Right now, many consumers would say ‘no’.”
About one in seven people indicated they would not be renewing their health insurance premiums in 2026, according to research.
The concerns go beyond the headline rate. Critics point to government incentives – such as the Medicare levy surcharge and lifetime health cover loading – which they argue push Australians into low-value policies primarily to avoid tax penalties rather than to seek genuine medical benefit. Data also indicates that the proportion of premiums returned to members as benefits has slid from around 90% before the pandemic to 85.9% as of September 2025, with the government projecting a recovery to 87% for the 12 months from April 1, 2026.
Private hospitals joined consumer groups in warning that steeper premiums do not automatically translate into better care. “Consumers are fast learning that the steeper premiums they pay each year do not translate into meeting the higher costs for the treatment and care they receive in hospitals,” said Australian Private Hospitals Association CEO Brett Heffernan.
Heffernan cited the profit performance of major insurers as evidence, noting that both Medibank and Bupa recorded above-average approved increases in 2024 and 2025, with Medibank’s after-tax profits rising to $573.7 million and Bupa’s surging by $182.1 million to $593.9 million over the same 12 months.
Over the five years to June 2024, net industry profits rose by 48%, and Medibank alone posted an operating profit of $741.5 million in 2024–25. Health professor Francesco Paolucci, a health economist, has argued that existing regulatory mechanisms have failed to contain premium inflation and that the system currently encourages participation without delivering genuine value to consumers.
